In a three-year research collaboration, Biotica will use its bioengineering technology to produce compounds that are not readily accessible via conventional medicinal chemistry approaches. GlaxoSmithKline (GSK) will apply
In his role as vice president of research and development, Ling manages IBT’s development of new tests in allergy and immunology. He brings with him over 25 years
Under the terms of the collaboration, Bristol-Myers Squibb agreed to pay ZymoGenetics an upfront cash payment of $85 million for the development and commercialization rights to PEG-Interferon lambda,
According to Cytori, the Celution system is a European-approved, cell processing device, which extracts and makes a dose of a patient’s own adipose tissue-derived adult stem and regenerative
EpiCept will direct its resources toward the registration of Ceplene in North America and clinical development programs. When complete, these actions are expected to reduce annual expenses by
Jonathan Rowe, chief operating officer for Gene Express stated, “The partnership between Funakoshi and Gene Express is extremely valuable as Funakoshi has the experience and capability to bring
Mr Valenti was most recently vice president and general manager of surgical devices (US) for Covidien. Prior, he spent 12 years with Johnson & Johnson, serving in a
Under the agreement, the total purchase price for Immtech Life Science is $2 million in cash. The company has received 30% of the total purchase price following the
The funding was led by MC Silicon Valley/Mitsubishi International and joined by existing investors including Montreux Equity Partners, Thomas Fogarty, and CN Investment Partners. In connection with the
The lawsuit is in response to the submission of an abbreviated new drug application to the FDA by Sandoz requesting approval to manufacture and sell generic versions of
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.